Thermo Fisher Scientific (TMO)

Wall Street closed the week at record highs, driven by strong earnings, new trade deals, upbeat macro data and Trump's AI and Fed moves.

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

U.S. stock futures were fluctuating on Thursday after rallying on Wednesday. Futures of major benchmark indices were mixed.

Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per share was 2.5% above analysts’ consensus estimates.

CNN Money Fear and Greed index rose to Extreme Greed zone on Wednesday. US-Japan pact raises baseline tariff to 15%

Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 12.3% in the afternoon session after the company reported second-quarter earnings and revenue that surpassed Wall Street estimates and raised its full-year financial guidance. The company posted adjusted earnings per share (EPS) of $5.36 on revenue of $10.85 billion. These results topped the average analyst estimates, which had projected an EPS of $5.22 on revenue of $10.65 billion. EPS is a widely used metric of a company's profitability. Following the strong quarterly performance, Thermo Fisher lifted its outlook for the full year. The company now expected 2025 revenue to be between $43.6 billion and $44.2 billion, raising the lower end of its previous forecast. It also increased its adjusted EPS guidance to a range of $22.22 to $22.84. The better-than-expected results were driven by growth in its Life Sciences Solutions and Lab Products & Biopharma Services divisions.

Thermo Fisher beat Q2 estimates, raised its 2025 guidance, and announced a CFO transition as easing tariffs support an improved outlook.

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per share was 2.3% above analysts’ consensus estimates.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs.

Life sciences company Thermo Fisher (NYSE:TMO) will be announcing earnings results this Wednesday before the bell. Here’s what investors should know.

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.